Press Releases Mateon Therapeutics, Inc. OTC Markets

Equities

MATN

US57667K1097

End-of-day quote OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

Apr. 12	Oncotelic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 25	Oncotelic Therapeutics, Inc. Announces Linkage of Cancer and Lupus in Gliomas Patients	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.	Apr. 29	AQ
Oncotelic Therapeutics, Inc. - Linkage of Cancer and Lupus in Gliomas Patients	Mar. 26	AQ
Linkage of Cancer and Lupus in Gliomas Patients	Mar. 25	AQ
Invitation to Participate in STOP-PC Clinical Trial	Mar. 04	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024 (Updated)	Feb. 21	AQ
Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients	Jan. 16	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	Dec. 22	AQ
Oncotelic Therapeutics Announces Opening of GMP Manufacturing Plant	Dec. 18	AQ
Oncotelic Therapeutics Announces CEO to Discuss Proprietary AI Technology at Ibero-American Chatbot Summit	Nov. 29	AQ
Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.	Nov. 28	AQ
Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results	Nov. 15	AQ
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023	23-08-28	AQ
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023	23-08-25	AQ
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer	23-08-23	AQ
Four Potentially Undervalued OTC Stocks (DDDX, OTLC, AABB, UNRV)	23-06-26	AQ
Oncotelic Launches PR Chatbot	23-06-12	AQ
Oncotelic Participating at 2023 BIO International Convention	23-05-16	AQ
Oncotelic Launches PDAO SEC Chatbot	23-04-24	AQ
ONCOTELIC THERAPEUTICS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	23-04-20	AQ
Oncotelic Therapeutics and Vectara Announce Strategic Partnership to Transform Pharmaceutical Research with Large Language Model Technology	23-04-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mateon Therapeutics, Inc. OTC Markets

Equities

MATN

US57667K1097

Press Releases

Filters